SCHEMBL29965367

SCHEMBL29965367

NS(=O)(=O)c1cc(Oc2c(Cl)cc(Br)cc2Cl)ccc1O

nearest known ligand 0.50

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 15/20 0.50
▸ THRA P10827 11/20 0.50
▸ PTGES2 Q9H7Z7 1/20 0.39
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ SOS1 Q07889 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23663250 1.00 THRB (0.50) THRBTHRAPTGES2CA1CA2
SCHEMBL29965090 0.89 THRB (0.47) THRBTHRA
SCHEMBL23663173 0.89 THRB (0.47) THRBTHRA
SCHEMBL26401642 0.84 THRB (0.40) THRBTHRAPTGES2CA1CA2
SCHEMBL23663343 0.82 THRB (0.46) THRBTHRAPTGES2
SCHEMBL29965585 0.82 PKM (0.45) THRBTHRAPTGES2CA1CA2
SCHEMBL23663257 0.82 PKM (0.45) THRBTHRAPTGES2CA1CA2
SCHEMBL26410468 0.80 THRB (0.50) THRBTHRA
SCHEMBL26410336 0.80 THRB (0.50) THRBTHRA
SCHEMBL30611111 0.77 THRB (0.43) THRBTHRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250320197-A1 THYROID HORMONE RECEPTOR AGONISTS AND USE THEREOF ECCOGENE INC (US) 2025-10-16 — — US disclosed
US-12291518-B2 Thyroid hormone receptor agonists and use thereof ECCOGENE INC. (US) 2025-05-06 — — US disclosed
CN-115244037-B Substituted triazinones as thyroid hormone receptor agonists 诚益生物(美国)公司 2024-10-25 — — CN disclosed
US-11780825-B2 Thyroid hormone receptor agonists and use thereof ECCOGENE (SHANGHAI) CO., LTD. (CN) 2023-10-10 — — US disclosed
EP-4090652-A1 SUBSTITUTED TRIAZINONES AS THYROID HORMONE RECEPTOR AGONISTS Eccogene (Shanghai) Co., Ltd. (CN) 2022-11-23 — — EP disclosed
CN-115244037-A Substituted triazinones as thyroid hormone receptor agonists 上海诚益生物科技有限公司 2022-10-25 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11780825-B2 Thyroid hormone receptor agonists and use thereof TSHR, THRA, THRB THRB 3/4885THRA 2/4885PTGES2 3266/4885
US-12291518-B2 Thyroid hormone receptor agonists and use thereof TSHR, THRA, THRB THRB 3/4885THRA 2/4885PTGES2 3266/4885
US-20250320197-A1 THYROID HORMONE RECEPTOR AGONISTS AND USE THEREOF TSHR, THRA, THRB THRB 3/4885THRA 2/4885PTGES2 3266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback